Ex-Celgene, Sanofi, Stryker Execs Accused Of Insider Trading

Law360, New York (November 19, 2012, 7:02 PM EST) -- Onetime Celgene Corp., Sanofi-Aventis and Stryker Corp. executives were among six people hit with criminal charges Monday for allegedly participating in a New Jersey-based insider trading network that used confidential information on acquisitions or other corporate developments to generate more than $1.4 million in illegal profits.

From 2007 to this year, John Lazorchak, a former director of financial reporting at Celgene, repeatedly shared tips with friend Mark Cupo, who was a director of accounting and reporting at Sanofi, authorities said. Cupo allegedly funneled that information to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.